Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Myriad Genetics Inc (NASDAQ:MYGN)

20.43
BATS BZX Real-Time Price
As of 12:07pm ET
 -0.115 / -0.56%
Today’s Change
19.10
Today|||52-Week Range
46.24
-52.68%
Year-to-Date

Today’s Trading

Previous close20.54
Today’s open20.38
Day’s range20.24 - 20.65
Volume32,498
Average volume (3 months)1,314,924
Market cap$1.4B
Dividend yield--
Data as of 12:07pm ET, 08/31/2016

Growth & Valuation

Earnings growth (last year)+58.33%
Earnings growth (this year)-34.95%
Earnings growth (next 5 years)+5.60%
Revenue growth (last year)+4.25%
P/E ratio11.9
Price/Sales2.98
Price/Book1.90

Competitors

 Today’s
change
Today’s
% change
AAAPAdvanced Accelerator...+0.06+0.17%
VIVOMeridian Bioscience ...+0.02+0.08%
QDELQuidel Corp-0.35-1.61%
NEOGNeogen Corp-0.01-0.02%
Data as of 12:06pm ET, 08/31/2016

Financials

Next reporting dateNovember 1, 2016
EPS forecast (this quarter)$0.27
Annual revenue (last year)$753.8M
Annual profit (last year)$125.3M
Net profit margin16.62%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark C. Capone
Executive Vice President-
International Operations
Gary A. King
Corporate headquarters
Salt Lake City, Utah

Forecasts

Search for Jobs